more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$70.37 USD

+0.14 (0.20%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $70.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Henry Schein (HSIC) Reports Break-Even Earnings for Q2

by Zacks Equity Research Published on August 04,2020

Henry Schein (HSIC) delivered earnings and revenue surprises of 100.00% and 19.98%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

HSICPositive Net Change

Why Earnings Season Could Be Great for Henry Schein (HSIC)

by Zacks Equity Research Published on August 03,2020

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

HSICPositive Net Change

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research Published on July 28,2020

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HSICPositive Net Change

Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research Published on July 28,2020

Henry Schein's (HSIC) medical business' PPE sales are likely to have boosted Q2 performance amid the coronavirus pandemic.

Why the Earnings Surprise Streak Could Continue for Henry Schein (HSIC)

by Zacks Equity Research Published on July 24,2020

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HSICPositive Net Change

Henry Schein Banks on Dental Consumable Amid Coronavirus Woes

by Zacks Equity Research Published on July 13,2020

Henry Schein (HSIC) seems upbeat about its dental technology business, Henry Schein One.

medical

Henry Schein Medical to Expand in Telemedicine With VisualDx

by Zacks Equity Research Published on July 13,2020

Henry Schein's (HSIC) VisualDx system to be integrated with Medpod's technology infrastructure for improved patient outcome.

medical

3 MedTech Stocks to Buy Amid Intensifying Coronavirus Fears

by Trina Mukherjee Published on July 02,2020

Let's keep a watch on three stocks that have shown tremendous promise amid the pandemic.

medical

Near-Term Outlook Bleak for Medical Dental Supplies Industry

by Trina Mukherjee Published on June 22,2020

Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.

medical

Henry Schein Dental Software Arm May Rebound Despite Pandemic

by Zacks Equity Research Published on June 19,2020

Henry Schein (HSIC) also seems to be upbeat about its dental technology business, Henry Schein One.

medical

Why Is Henry Schein (HSIC) Up 20% Since Last Earnings Report?

by Zacks Equity Research Published on June 04,2020

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HSICPositive Net Change

Henry Schein Sales Drop on Coronavirus Woes, Costs Rise

by Zacks Equity Research Published on May 26,2020

Henry Schein (HSIC) registers dismal performance within Dental business on suspension of non-emergency procedures in response to the pandemic.

medical

Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research Published on May 05,2020

Henry Schein (HSIC) sees dismal performance by Dental arm in Q1 due to disruptions resulting from the coronavirus pandemic.

Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research Published on April 28,2020

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HSICPositive Net Change

Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research Published on April 28,2020

Contribution from Henry Schein's (HSIC) medical business in the form of point-of-care antibody rapid test is likely to have boosted Q1 performance amid the coronavirus pandemic.

medical

Healthcare ETFs to Gain on Progress in COVID-19 Antibody Tests

by Sweta Jaiswal, FRM Published on April 16,2020

Along with molecular testing, antibody testing is gaining immense prominence as economies are struggling to reopen.

etfs

Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress

by Sweta Jaiswal, FRM Published on April 06,2020

It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.